Answers are grounded in this paper and cite their sources.
This analysis reveals heightened pancreatic cancer risk in patients with skeletal muscle loss, suggesting the need for close monitoring.
Skeletal muscle mass loss was an independent risk factor for all-cause mortality, and it might be associated with the risk factor for the incidence of pancreatic cancer, particularly IPMN-derived carcinoma in patients with IPMN. Patients with a low PMI and minimal comorbidities might be better to undergo long-term surveillance due to their increased risk of pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Oda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: